All articles tagged: Malignant neoplasm of ill-defined sites within the digestive system (C26.9)
![]()
Evalytics
15 April at 05.54 PM
Accelerated aging linked to cancer risk in younger adults, research showsYounger adults are experiencing increased cancer rates, possibly linked to accelerated biological aging. Researchers analyzed data from the UK Biobank, finding associations between faster aging and higher cancer risks. This study suggests potential for targeted screenings and interventions based on accelerated aging markers to mitigate cancer risks in younger individuals. |
![]()
Evalytics
29 January at 05.53 PM
'Cancer-cooling' protein puts bowel cancer on iceANU researchers discovered that Ku70, an immune protein, can be activated to inhibit bowel cancer by detecting damaged DNA in cells, potentially improving screening and treatment. |
![]()
HealthDay
29 January at 03.40 PM
Addition of Durvalumab, Bevacizumab to TACE Beneficial in Liver CancerFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) improves progression-free survival (PFS), according to a study presented at the American Society of Clinical Oncology annual Gastrointestinal Cancers Symposium, held from Jan. |
![]()
HealthDay
26 January at 10.12 PM
Cancer Risk Increased With Recent Weight LossIndividuals with recent weight loss have a significantly increased risk for cancer during the subsequent 12 months, according to a study published online in the Jan. 23/30 issue of the Journal of the American Medical Association.Qiao-Li Wang, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues examined the rates of subseq |
![]()
HealthDay
18 January at 11.04 PM
Risk for Cancer Increased for Relatives of Patients With LeukemiaRelatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according to a study published in the February issue of Cancer Epidemiology.Nikolaj Juul Nitschke, from Copenhagen University Hospital in Denmark, and colleagues estimated t |
![]()
Evalytics
20 November at 08.49 PM
New tumor marker can detect gastric cancer with nearly 90% accuracyResearchers at Nagoya University have discovered that the protein SDF-4 is a highly effective marker for early detection of gastric cancer, with 89% sensitivity and 99% specificity. This breakthrough, published in Scientific Reports, indicates that simple blood tests for SDF-4 could significantly improve early diagnosis and treatment of various cancers, including gastric, esophageal, and colorecta |
![]()
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
![]()
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |